4
Clinical Trials associated with SJP-0135SJP-0135 Phase 3 -A Multicenter, Randomized, Double-Masked, Active-Controlled, Parallel-Group Study in Patients with Primary Open Angle Glaucoma or Ocular Hypertension
Start Date15 Sep 2023 |
Sponsor / Collaborator- |
/ CompletedNot Applicable A phase I clinical pharmacology study of SJP-0135 - A phase I clinical pharmacology study of SJP-0135
/ CompletedNot Applicable A phase III comparative study to evaluate the efficacy and safety of SJP-0135 versus timolol in patients with primary open-angle glaucoma or ocular hypertension - A comparative study to evaluate the efficacy and safety of SJP-0135 versus timolol in patients with primary open-angle glaucoma or ocular hypertension
100 Clinical Results associated with SJP-0135
100 Translational Medicine associated with SJP-0135
100 Patents (Medical) associated with SJP-0135
100 Deals associated with SJP-0135